Product Code: RP-ID-10070594 |
Published Date: 21 Mar 2025 |
Region: Global |
Category: Healthcare & Pharmaceuticals |
Report ID: 10070594
Market Overview:
Tumor Ablation Market Analysis by Mode of Treatment (Surgical Ablation, Percutaneous Ablation, and Laparoscopic Ablation); by Application (Kidney Cancer, Liver Cancer, and Others); and by Technology (RF Ablation, Microwave Ablation, and Others) - Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Tumor Ablation Market Scope Report
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~14% |
|
Base Year Market Size (2022) |
~ USD 2 Billion |
|
Forecast Year Market Size (2033) |
~ USD 5 Billion |
Global Tumor Ablation Market Highlights Over 2023 - 2033
The global tumor ablation market is estimated to garner a revenue of around USD 5 billion by the end of 2033 by growing at a CAGR of ~14% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of ~USD 2 billion in the year 2022. Tumor ablation is an image-guided method where a needle electrode is guided toward cancerous cells with the help of techniques, including magnetic resonance imaging (MRI) or computed tomography (CT). The cancerous cells are then destroyed using heat. The large prevalence of cancer worldwide is the main factor affecting the growth of the global tumor ablation market. For instance, according to the World Health Organization (WHO), cancer constitutes the leading cause of death globally, with more than 9 million deaths, only in 2020.
GET A SAMPLE COPY OF THIS REPORT
Cancer occurs from the development of normal cells into tumor cells as a person’s genetic factors interact with external factors, including physical carcinogens, chemical carcinogens, and biological carcinogens.
Global Tumor Ablation Market: Growth Drivers and Challenges
Growth Drivers
-
Rapid Growth of the Geriatric Population – It is estimated that the global population falling under 60 years and above will reach ~23% by 2050. Older patients with cancer are growing proportionally with the growth in the elderly population. It is the biological changes that come with aging which make the older population especially susceptible to cancer. Further, the heterogeneity that can be observed in the functional status and the general health of older people make cancer treatment for the group much more challenging and increase the demand for minimally invasive procedures, including tumor ablation.
-
Increasing Number of Hospitals Worldwide – For instance, the number of hospitals in Japan and Korea exceeded 8000 and 4000, respectively, in 2020.
-
Growth in Healthcare Investments – According to the Organization for Economic Co-operation and Development (OECD), the expenditure on healthcare as a share of gross domestic product (GDP) across OECD countries was 9.7% in 2020.
-
Considerable Growth of Diagnostic Imaging Procedures – It is estimated that in the United States (U.S.), around 280 computer tomography (CT) scans are done per 1000 inhabitants annually as of 2019.
Challenges
-
High Expenses of Treatment Procedures
-
Stringent Healthcare Regulations in Some Parts of the World
-
Lack of Skilled Professionals to Perform the Procedure
The global tumor ablation market is segmented and analyzed for demand and supply by application into kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and other cancers. Of these, the liver cancer segment is anticipated to hold the largest market size by the end of 2033. The prevalence of primary liver cancer and bile duct cancer among the general population is the major reason driving segmental growth. It is estimated that in the U.S. alone, more than 7999 people get diagnosed with liver cancer every year.
Global Tumor Ablation Market Regional Synopsis
Regionally, the global tumor ablation market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America region is projected to hold the largest market share by the end of 2033. The increasing prevalence of cancer, government support for quality healthcare, availability of reimbursement, and high purchasing power parity is the major factor driving the regional market growth. For instance, only in 2018, the number of new cancer cases recorded in the region is about 2 million, while there were more than 692,999 cancer-related deaths.
Market Segmentation
Our in-depth analysis of the global tumor ablation market includes the following segments:
|
By Mode of Treatment |
|
|
By Application |
|
|
By Technology |
|
Key Companies Dominating the Global Tumor Ablation Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global tumor ablation market that are included in our report are Medtronic plc, AngioDynamics, Inc., HealthTronics, Inc., Boston Scientific Corporation, EDAP TMS SA, Sonablate Corporation, Misonix, Inc., Smith & Nephew PLC, Theraclion S. A., Biotronik SE & Co. KG, and others.
Global Tumor Ablation Market: Latest Developments
-
August, 2022: Medtronic plc announced completing the acquisition of Affera, Inc., thereby expanding its cardiac ablation portfolio with its mapping and navigation platform.
-
June, 2021: Boston Scientific Corporation announced acquiring the remaining shares of Farapulse, Inc. to complement the company’s electrophysiology portfolio by including the non-thermal ablation method FARAPULSE Pulsed Field Ablation (PFA) System for treating cardiac arrhythmias, including atrial fibrillation (AF).
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
- Medtronic plc
- AngioDynamics Inc.
- HealthTronics Inc.
- Boston Scientific Corporation
- EDAP TMS SA
- Sonablate Corporation
- Misonix Inc.
- Smith & Nephew PLC
- Theraclion S. A.
- Biotronik SE & Co. KG
Related Reports
Proof of Quality & Reliability
